PATENT CLAIM ANALYSIS

Application Number: 16165985
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["552", "293000"]

Abstract:
Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein.

Claim (Index 2):
The method according to  claim 1 , comprising administering a therapeutically effective amount or physiologically effective amount of one or more compounds selected from the group consisting of Formula Ia, Formula IIa, and mixtures thereof, or a stereoisomer, a mixture of stereoisomers, a solvate, or a hydrate thereof.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 97.0
- Lexical Diversity: 1.34694
- Patent Class: 552.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12555700', '15208549', '14155288', '13651330', '14605937']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7024638312998895
- 35 USC 102 Novelty (BERT): 0.7576998588915872
- Combined Prediction Score: 0.7079874340590593
- Mean Citation Score: 558.733396
- Max Citation Score: 745.55566
- Similarity Product: 718.1055934557486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test